Data Collective IV GP, LLC
- SEC CIK
- 0001664974
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 4
- −1 vs. Q2 2025
- Portfolio value
- $68.0M
- −$61.9M (−47.7%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| EVLVEvolv Technologies Holdings, Inc. | COM CL A | 5,000,000 | $37.8M | 55.5% | −4,681,281−48.4% | Reduced | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 5,941,120 | $29.0M | 42.6% | 00.0% | Unchanged | History |
| DFTXDefinium Therapeutics, Inc. | Stock | 100,350 | $1.18M | 1.7% | 00.0% | Unchanged | History |
| ROIVRoivant Sciences Ltd. | SHS | 3,875 | $58.6K | 0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2025 (1)
Positions held at the end of Q2 2025 that are gone from this filing.